BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3057901)

  • 1. Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment.
    Hurd DD; LeBien TW; Lasky LC; Haake RJ; Ramsay NK; Kim TH; Levine EG; McGlave PB; Bloomfield CD; Peterson BA
    Am J Med; 1988 Dec; 85(6):829-34. PubMed ID: 3057901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging.
    Weisdorf DJ; Haake R; Miller WJ; McGlave PB; LeBien TW; Vallera DA; Lasky LC; Kim TH; Peterson BA; Ramsay NK
    Bone Marrow Transplant; 1991 Aug; 8(2):135-42. PubMed ID: 1933055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.
    Freedman AS; Takvorian T; Anderson KC; Mauch P; Rabinowe SN; Blake K; Yeap B; Soiffer R; Coral F; Heflin L
    J Clin Oncol; 1990 May; 8(5):784-91. PubMed ID: 2332768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.
    Takvorian T; Canellos GP; Ritz J; Freedman AS; Anderson KC; Mauch P; Tarbell N; Coral F; Daley H; Yeap B
    N Engl J Med; 1987 Jun; 316(24):1499-505. PubMed ID: 3295542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.
    Philip T; Armitage JO; Spitzer G; Chauvin F; Jagannath S; Cahn JY; Colombat P; Goldstone AH; Gorin NC; Flesh M
    N Engl J Med; 1987 Jun; 316(24):1493-8. PubMed ID: 3295541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma.
    Brown JR; Gaudet G; Friedberg JW; Neuberg D; Mauch P; Kutok JL; Takvorian T; Fisher DC; Gribben JG; Kim H; Nadler LM; Freedman AS
    Leuk Lymphoma; 2004 Feb; 45(2):315-20. PubMed ID: 15101717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.
    Verdonck LF; van Putten WL; Hagenbeek A; Schouten HC; Sonneveld P; van Imhoff GW; Kluin-Nelemans HC; Raemaekers JM; van Oers RH; Haak HL
    N Engl J Med; 1995 Apr; 332(16):1045-51. PubMed ID: 7898521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry.
    Williams CD; Pearce R; Taghipour G; Green ES; Philip T; Goldstone AH
    J Clin Oncol; 1994 Nov; 12(11):2415-22. PubMed ID: 7964958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation.
    Phillips GL; Fay JW; Herzig RH; Lazarus HM; Wolff SN; Lin HS; Shina DC; Glasgow GP; Griffith RC; Lamb CW
    Blood; 1990 Feb; 75(4):831-8. PubMed ID: 2302456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
    Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
    Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autologous bone marrow transplantation in children with acute leukemia or non-Hodgkin's lymphoma].
    Emminger W; Hinterberger W; Emminger-Schmidmeier W; Peters C; Fink FM; Zoubek A; Haas OA; Höcker P; Hawliczek R; Knapp W
    Wien Med Wochenschr; 1991; 141(9-10):225-8. PubMed ID: 1683071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue. The Newcastle and Northern Region Lymphoma Group.
    Taylor PR; Jackson GH; Lennard AL; Lucraft H; Proctor SJ
    Br J Cancer; 1993 Feb; 67(2):383-7. PubMed ID: 8431371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.
    Freedman AS; Takvorian T; Neuberg D; Mauch P; Rabinowe SN; Anderson KC; Soiffer RJ; Spector N; Grossbard M; Robertson MJ
    J Clin Oncol; 1993 May; 11(5):931-6. PubMed ID: 8487057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
    Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
    J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.
    Sharp JG; Kessinger A; Mann S; Crouse DA; Armitage JO; Bierman P; Weisenburger DD
    J Clin Oncol; 1996 Jan; 14(1):214-9. PubMed ID: 8558200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry.
    Williams CD; Goldstone AH; Pearce RM; Philip T; Hartmann O; Colombat P; Santini G; Foulard L; Gorin NC
    J Clin Oncol; 1996 Sep; 14(9):2454-64. PubMed ID: 8823323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second autologous transplantation after failure of a first autologous transplant in 18 patients with non-Hodgkin's lymphoma.
    Lenain C; Dumontet C; Gargi T; Chassagne C; Berger F; Perol D; Garnier M; Coiffier B; Blay JY
    Hematol J; 2004; 5(5):403-9. PubMed ID: 15448666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation.
    Vose JM; Armitage JO; Bierman PJ; Weisenburger DD; Hutchins M; Dowling MD; Moravec DF; Sorensen S; Okerbloom J; Bascom G
    Am J Med; 1989 Sep; 87(3):285-8. PubMed ID: 2672808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.